Product Name: Human CD20 Antibody (Ocaratuzumab, Research Use)
Catalog Number: NBR-0754
Target Name: CD20
Trade Name: Ocaratuzumab
Antibody Drug Description: Ocaratuzumab is a novel Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody (mAb) designed for effective antibody-dependent cell-mediated cytotoxicity (ADCC) at very low concentrations that may facilitate sub-cutaneous (vs. intravenous) dosing. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CD20
Synonyms: Bp35; Bp35; MS4A1; LEU-16
Target Description: B-lymphocyte-specific membrane protein that plays a role in the regulation of cellular calcium influx necessary for the development, differentiation, and activation of B-lymphocytes.
Ensembl: ENSG00000156738
Uniprot: P11836